Cargando…

New Pyrazolobenzothiazine Derivatives as Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors

[Image: see text] We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against hepatitis C virus (HCV) NS5B polymerase, a validated and promising anti-HCV target. Herein we describe the design, synthesis, enzymatic, and cellular characterization of new pyrazolobe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manfroni, Giuseppe, Manvar, Dinesh, Barreca, Maria Letizia, Kaushik-Basu, Neerja, Leyssen, Pieter, Paeshuyse, Jan, Cannalire, Rolando, Iraci, Nunzio, Basu, Amartya, Chudaev, Maxim, Zamperini, Claudio, Dreassi, Elena, Sabatini, Stefano, Tabarrini, Oriana, Neyts, Johan, Cecchetti, Violetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203399/ https://www.ncbi.nlm.nih.gov/pubmed/24654886 http://dx.doi.org/10.1021/jm401688h

Ejemplares similares

Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors
por: Cannalire, Rolando, et al.
Publicado: (2020)

C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors
por: Felicetti, Tommaso, et al.
Publicado: (2020)

From Quinoline to Quinazoline‐Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search
por: Cedraro, Nicholas, et al.
Publicado: (2021)

Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli
por: Machado, Diana, et al.
Publicado: (2017)

p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening
por: Astolfi, Andrea, et al.
Publicado: (2015)

1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity
por: Desantis, Jenny, et al.
Publicado: (2020)

Pharmacological Agents Targeting the Cellular Prion Protein
por: Barreca, Maria Letizia, et al.
Publicado: (2018)

Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity
por: Nizi, Maria Giulia, et al.
Publicado: (2022)

From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors
por: Massari, Serena, et al.
Publicado: (2018)

Inhibition of Influenza Virus Polymerase by Interfering with Its Protein–Protein Interactions
por: Massari, Serena, et al.
Publicado: (2020)

Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs
por: Felicetti, Tommaso, et al.
Publicado: (2020)

Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy
por: Marsili, Giulia, et al.
Publicado: (2023)

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
por: Kaushik-Basu, Neerja, et al.
Publicado: (2008)

Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase
por: Massari, Serena, et al.
Publicado: (2021)

Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
por: Musiu, Simone, et al.
Publicado: (2020)

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication
por: Delang, Leen, et al.
Publicado: (2012)

Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach
por: Palazzotti, Deborah, et al.
Publicado: (2019)

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
por: Esposito, Francesca, et al.
Publicado: (2023)

Deciphering the Role of Bovine Viral Diarrhea Virus Non-Structural NS4B Protein in Viral Pathogenesis
por: Bashir, Shahbaz, et al.
Publicado: (2020)

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2012)

Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
por: Nizi, Maria Giulia, et al.
Publicado: (2023)

Molecular strategies to inhibit the replication of RNA viruses
por: Leyssen, Pieter, et al.
Publicado: (2008)

DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
por: Coelmont, Lotte, et al.
Publicado: (2010)

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection
por: Delang, L., et al.
Publicado: (2016)

From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia
por: Astolfi, Andrea, et al.
Publicado: (2022)

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
por: Nizi, Maria Giulia, et al.
Publicado: (2022)

Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents †
por: Küçükgüzel, Ş. Güniz, et al.
Publicado: (2013)

Trigocherrierin A, a Potent Inhibitor of Chikungunya Virus Replication
por: Bourjot, Mélanie, et al.
Publicado: (2014)

Current global status & impact of human papillomavirus vaccination: Implications for India
por: Sankaranarayanan, Rengaswamy, et al.
Publicado: (2016)

The Putative Metal Coordination Motif in the Endonuclease Domain of Human Parvovirus B19 NS1 Is Critical for NS1 Induced S Phase Arrest and DNA Damage
por: Kivovich, Violetta, et al.
Publicado: (2011)

Flaviviral NS4b, chameleon and jack‐in‐the‐box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention
por: Zmurko, Joanna, et al.
Publicado: (2015)

Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents
por: Zamperini, C., et al.
Publicado: (2017)

Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India
por: Panda, Sujogya K., et al.
Publicado: (2017)

[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes
por: Murthy, Sudarshan, et al.
Publicado: (2023)

Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy
por: Lewis, Mark G, et al.
Publicado: (2010)

Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery
por: Vignaroli, Giulia, et al.
Publicado: (2016)

A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2011)

Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species
por: Lanko, Kristina, et al.
Publicado: (2021)

Molecular Characterization and Evolutionary Analyses of Carnivore Protoparvovirus 1 NS1 Gene
por: Mira, Francesco, et al.
Publicado: (2019)

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
por: Cannalire, Rolando, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_046msbk3kj9nukq87je26gjg43